155 related articles for article (PubMed ID: 38073447)
1. Anatomic prognostic factors and their potential roles in refining M1 classification for de novo metastatic nasopharyngeal carcinoma.
Lu TZ; Zeng FJ; Hu YJ; Fang M; Zhong FY; Chen BJ; Zhang H; Guo QJ; Pan JJ; Gong XC; Huang SH; Liao ZH; Xia Y; Li JG
Cancer Med; 2023 Dec; 12(24):22091-22102. PubMed ID: 38073447
[TBL] [Abstract][Full Text] [Related]
2. Refining TNM-8 M1 categories with anatomic subgroups for previously untreated de novo metastatic nasopharyngeal carcinoma.
Chan SK; Lin C; Huang SH; Chau TC; Guo QJ; O'Sullivan B; Lam KO; Chau SC; Chan SY; Tong CC; Vardhanabhuti V; Kwong DLW; So TH; Ng CY; Leung TW; Luk MY; Lee AWM; Choi HCW; Pan JJ; Lee VHF
Oral Oncol; 2022 Mar; 126():105736. PubMed ID: 35121396
[TBL] [Abstract][Full Text] [Related]
3. An Exploratory Study of Refining TNM-8 M1 Categories and Prognostic Subgroups Using Plasma EBV DNA for Previously Untreated De Novo Metastatic Nasopharyngeal Carcinoma.
Chan SK; O'Sullivan B; Huang SH; Chau TC; Lam KO; Chan SY; Tong CC; Vardhanabhuti V; Kwong DL; Ng CY; Leung TW; Luk MY; Lee AW; Choi HC; Lee VH
Cancers (Basel); 2022 Apr; 14(8):. PubMed ID: 35454830
[TBL] [Abstract][Full Text] [Related]
4. Image-based Multilevel Subdivision of M1 Category in TNM Staging System for Metastatic Nasopharyngeal Carcinoma.
Shen L; Li W; Wang S; Xie G; Zeng Q; Chen C; Shi F; Zhang Y; Wu M; Shu W; Pan C; Xia Y; Wu P
Radiology; 2016 Sep; 280(3):805-14. PubMed ID: 27023116
[TBL] [Abstract][Full Text] [Related]
5. Establishment and validation of M1 stage subdivisions for de novo metastatic nasopharyngeal carcinoma to better predict prognosis and guide treatment.
Zou X; You R; Liu H; He YX; Xie GF; Xie ZH; Li JB; Jiang R; Liu LZ; Li L; Zhang MX; Liu YP; Hua YJ; Guo L; Qian CN; Mai HQ; Chen DP; Luo Y; Shen LF; Hong MH; Chen MY
Eur J Cancer; 2017 May; 77():117-126. PubMed ID: 28391025
[TBL] [Abstract][Full Text] [Related]
6. Establishing subdivisions of M1 stage nasopharyngeal carcinoma based on decision tree classification: A multicenter retrospective study.
Liu Y; Zuo ZC; Zeng XY; Ma J; Ma CX; Chen RZ; Liang ZG; Chen KH; Li L; Qu S; Lu JY; Zhu XD
Oral Oncol; 2024 Jun; 153():106834. PubMed ID: 38718458
[TBL] [Abstract][Full Text] [Related]
7. Subdivision of M category for nasopharyngeal carcinoma with synchronous metastasis: time to expand the M categorization system.
Shen LJ; Wang SY; Xie GF; Zeng Q; Chen C; Dong AN; Huang ZM; Pan CC; Xia YF; Wu PH
Chin J Cancer; 2015 Aug; 34(10):450-8. PubMed ID: 26264052
[TBL] [Abstract][Full Text] [Related]
8. Oligometastases in AJCC stage IVc nasopharyngeal carcinoma: A subset with better overall survival.
Tian YH; Zou WH; Xiao WW; Zeng L; Yuan X; Bai L; Lu T; Tian Y; Han F
Head Neck; 2016 Aug; 38(8):1152-7. PubMed ID: 27220062
[TBL] [Abstract][Full Text] [Related]
9. Development of a ten-signature classifier using a support vector machine integrated approach to subdivide the M1 stage into M1a and M1b stages of nasopharyngeal carcinoma with synchronous metastases to better predict patients' survival.
Jiang R; You R; Pei XQ; Zou X; Zhang MX; Wang TM; Sun R; Luo DH; Huang PY; Chen QY; Hua YJ; Tang LQ; Guo L; Mo HY; Qian CN; Mai HQ; Hong MH; Cai HM; Chen MY
Oncotarget; 2016 Jan; 7(3):3645-57. PubMed ID: 26636646
[TBL] [Abstract][Full Text] [Related]
10. Subdivision of Nasopharyngeal Carcinoma Patients with Bone-Only Metastasis at Diagnosis for Prediction of Survival and Treatment Guidance.
Sun XS; Liang YJ; Liu SL; Chen QY; Guo SS; Wen YF; Liu LT; Xie HJ; Tang QN; Li XY; Yan JJ; Tang LQ; Mai HQ
Cancer Res Treat; 2019 Oct; 51(4):1259-1268. PubMed ID: 30653745
[TBL] [Abstract][Full Text] [Related]
11. Metastatic characteristics associated with survival of synchronous metastatic nasopharyngeal carcinoma in non-epidemic areas.
Lin M; Yang Q; You R; Zou X; Duan CY; Liu YP; Huang PY; Xie YL; Wang ZQ; Liu T; Chen SY; Hua YJ; Chen MY
Oral Oncol; 2021 Apr; 115():105200. PubMed ID: 33610003
[TBL] [Abstract][Full Text] [Related]
12. Optimizing the treatment mode for de novo metastatic nasopharyngeal carcinoma with bone-only metastasis.
Lin C; Lin S; Zhu L; Lin S; Pan J; Xu Y
BMC Cancer; 2022 Jan; 22(1):35. PubMed ID: 34983459
[TBL] [Abstract][Full Text] [Related]
13. Defining a cohort of oligometastatic nasopharyngeal carcinoma patients with improved clinical outcomes.
Chee J; Liu X; Eu D; Loh T; Ho F; Wong LC; Tham I; Tan CS; Goh BC; Lim CM
Head Neck; 2020 May; 42(5):945-954. PubMed ID: 31909854
[TBL] [Abstract][Full Text] [Related]
14. [Evaluation of the prognostic significance of refinement and stratification of distant metastasis status in 1016 cases of nasopharyngeal carcinoma].
Pan CC; Lu J; Chen P; Li X; Jin YD; Zhao M; Xia YF; Wu PH
Zhonghua Zhong Liu Za Zhi; 2013 Aug; 35(8):595-9. PubMed ID: 24314217
[TBL] [Abstract][Full Text] [Related]
15. M1 stage subdivision and treatment outcome of patients with bone-only metastasis of nasopharyngeal carcinoma.
Shen L; Dong J; Li S; Wang Y; Dong A; Shu W; Wu M; Pan C; Xia Y; Wu P
Oncologist; 2015 Mar; 20(3):291-8. PubMed ID: 25660157
[TBL] [Abstract][Full Text] [Related]
16. Taxane/gemcitabine-containing chemotherapy plus locoregional IMRT for patients with de novo metastatic nasopharyngeal carcinoma: the treatment outcomes and prognostic factors analysis.
Du C; Ni M; Jiang J; Kong F; Zhai R; Lv Y; Hu C; Ying H
Eur Arch Otorhinolaryngol; 2022 Aug; 279(8):3947-3956. PubMed ID: 34981158
[TBL] [Abstract][Full Text] [Related]
17. Development and validation of a gene expression-based signature to predict distant metastasis in locoregionally advanced nasopharyngeal carcinoma: a retrospective, multicentre, cohort study.
Tang XR; Li YQ; Liang SB; Jiang W; Liu F; Ge WX; Tang LL; Mao YP; He QM; Yang XJ; Zhang Y; Wen X; Zhang J; Wang YQ; Zhang PP; Sun Y; Yun JP; Zeng J; Li L; Liu LZ; Liu N; Ma J
Lancet Oncol; 2018 Mar; 19(3):382-393. PubMed ID: 29428165
[TBL] [Abstract][Full Text] [Related]
18. Challenges in the modification of the M1 stage of the TNM staging system for nasopharyngeal carcinoma: A study of 1027 cases and review of the literature.
Pan CC; Lu J; Yu JR; Chen P; Li W; Huang ZL; Zhao M; Huang ZM; Xia YF; Wu YH; Wu PH
Exp Ther Med; 2012 Aug; 4(2):334-338. PubMed ID: 23139721
[TBL] [Abstract][Full Text] [Related]
19. Prognostic value of baseline [18F]-fluorodeoxyglucose positron emission tomography parameters MTV, TLG and asphericity in an international multicenter cohort of nasopharyngeal carcinoma patients.
Zschaeck S; Li Y; Lin Q; Beck M; Amthauer H; Bauersachs L; Hajiyianni M; Rogasch J; Ehrhardt VH; Kalinauskaite G; Weingärtner J; Hartmann V; van den Hoff J; Budach V; Stromberger C; Hofheinz F
PLoS One; 2020; 15(7):e0236841. PubMed ID: 32730364
[TBL] [Abstract][Full Text] [Related]
20. The role of radiologic extranodal extension in predicting prognosis and chemotherapy benefit for T1-2 N1 nasopharyngeal carcinoma: A multicenter retrospective study.
Hu YJ; Lu TZ; Guo QJ; Zhang L; Xiao YP; Lin SJ; Zhou H; Zheng DC; Ding SR; Liu LZ; Gong XC; Li JG; Pan JJ; Xia YF
Radiother Oncol; 2023 Jan; 178():109436. PubMed ID: 36464180
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
